調劑藥局的市場:各產品類型，各治療領域，各用途，各地區- 規模，佔有率，展望，機會分析，2022年～2030年

市場動態

預計老年人口的增加將在預測期內推動市場增長。例如，根據 2022 年 2 月發布的數據，國際疼痛研究協會是一個致力於研究、教育和政策以了解、預防和治療疼痛的國際協會，該協會估計，到 2021 年，大約有 5000 萬老年人全世界的患者都說他們患有慢性疼痛。

本調查的主要特徵

• 本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球調劑藥局市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
• 並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
• 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
• 並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球調劑藥局市場的主要參與者之企業簡介。
• 藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 全球調劑藥局市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以透過全球調劑藥局市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

• 調查目的
• 前提條件
• 簡稱的說明

第2章 市場展望

• 報告內容
  • 市場定義和範圍
• 摘要整理
  • 市場概述:各產品類型
  • 市場概述:各治療領域
  • 市場概述:各應用領域
  • 市場概述:各地區
• 連貫機遇地圖(COM)

第3章 市場動態，法規，及趨勢的分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
• 影響分析
• 市場趨勢
• 最近的趨勢
• 收購和夥伴關係方案
• 技術概要
• 法律規章情景
• 開發平台分析
• PEST分析

第4章 全球調劑藥局市場-冠狀病毒(COVID-19)疫情的影響

• 整體影響
• 供需的影響
• COVID-19市場的影響

第5章 調劑藥局的全球市場:各產品類型，2017年～2030年

• 口服劑
• 膠囊劑
• 錠劑
• mixture
• Lolipop
• 錠劑
• 外用劑
• 凝膠
• 軟膏
• 乳霜
• 化妝水
• 直腸用
• 非口服劑
• 鼻腔用
• 眼科用劑
• 洗口劑

第6章 調劑藥局的全球市場，各治療領域，2017年～2030年

• 疼痛管理
• 荷爾蒙補充療法(HRT)
• 皮膚科領域
• 特殊藥物

第7章 調劑藥局的全球市場，各用途，2017年～2030年

• 兒童
• 成人病
• 老年
• 動物用醫藥品

第8章 調劑藥局的全球市場，各地區，2017年～2030年

• 北美
• 美國
• 加拿大
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他的南美地區
• 歐洲
• 英國
• 德國
• 義大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• ASEAN
• 澳洲
• 韓國
• 其他亞太地區
• 中東地區
• GCC
• 以色列
• 其他的中東地區
• 非洲
• 北非
• 中非
• 南非

第9章 競爭情形

• Avella Specialty Pharmacy
• Central Admixture Pharmacy Services
• Fagron
• Fresenius Kabi AG
• PharMEDium Services
• Institutional Pharmacy Solutions
• Cantrell Drug Company
• Triangle Compounding Pharmacies
• Lorraine's Pharmacy
• Rx3 Compounding Pharmacy
• B Braun Melsungen AG
• Clinigen Group PLC
• QuVa Pharma
• ITC Compounding Pharmacy
• Advanced Pharmacy

第10章 章節

• 調查手法
• 關於出版社

Compounded medications are prepared by compounding pharmacies to meet the needs of unique patients whose conditions cannot be treated by commercially accessible medications. The process of combining, blending, or changing substances to make a treatment specific to the requirements of a particular patient is known as drug compounding. Combining two or more medications is referred to as compounding. It may be essential to compound a drug for a patient who cannot be treated with an FDA-approved drug, such as one who has a dye allergy and needs a medication to be made without it, or a patient who is elderly or a child who is unable to swallow a tablet or capsule and needs a medication in a liquid dosage form. Hospitals, clinics, and other healthcare facilities' doctors occasionally provide patients compounded pharmaceuticals when an FDA-approved drug is not medically required to treat them.

Sometimes, when an Food and Drug Administration (FDA)-approved medication is not medically necessary to treat a patient, doctors in hospitals, clinics, and other healthcare institutions will give them compounded drugs. A compounding pharmacy is a specific type of pharmacy. They make medications for people who have certain medication needs or requirements.

Market Dynamics

Increasing geriatric population is expected to drive market growth over the forecast period. For instance, according to data published in February 2022, on International Association for the Study of Pain, which is an international learned society promoting research, education, and policies for the understanding, prevention, and treatment of pain, stated that, in 2021, about 50 million elder patients were suffering from chronic pain globally.

Key features of the study:

• This report provides in-depth analysis of the global compounding pharmacies market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global compounding pharmacies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Fagron, Fresenius Kabi AG, PharMEDium Services, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacies, Lorraine's Pharmacy, Rx3 Compounding Pharmacy, B Braun Melsungen AG, Clinigen Group PLC, QuVa Pharma, ITC Compounding Pharmacy, and Advanced Pharmacy
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global compounding pharmacies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compounding pharmacies market

Detailed Segmentation:

• Global Compounding Pharmacies Market, By Product Type:
  • Oral
    • Capsule
    • Tablets
    • Mixtures
    • Lollipops
    • Lozenges
  • Topical
    • Gels
    • Ointments
    • Cream
    • Lotions
  • Rectal
  • Parenteral
  • Nasal
  • Ophthalmic
  • Mouthwashes
• Global Compounding Pharmacies Market, By Therapeutic Area:
  • Pain Management
  • Hormone Replacement Therapy (HRT)
  • Dermatology
  • Specialty Drugs
• Global Compounding Pharmacies Market, By Application:
  • Pediatric
  • Adults
  • Geriatric
  • Veterinary
• Global Compounding Pharmacies Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Avella Specialty Pharmacy
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Central Admixture Pharmacy Services
  • Fagron
  • Fresenius Kabi AG
  • PharMEDium Services
  • Institutional Pharmacy Solutions
  • Cantrell Drug Company
  • Triangle Compounding Pharmacies
  • Lorraine's Pharmacy
  • Rx3 Compounding Pharmacy
  • B Braun Melsungen AG
  • Clinigen Group PLC
  • QuVa Pharma
  • ITC Compounding Pharmacy
  • Advanced Pharmacy

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Therapeutic Area
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• Pipeline Analysis
• PEST Analysis

4. Global Compounding Pharmacies Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Compounding Pharmacies Market, By Product Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Capsule
• Tablets
• Mixtures
• Lollipops
• Lozenges
• Topical
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Gels
• Ointments
• Cream
• Lotions
• Rectal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Parenteral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Nasal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Ophthalmic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Mouthwashes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Compounding Pharmacies Market, By Therapeutic Area, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Pain Management,
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Hormone Replacement Therapy (HRT)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Dermatology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Specialty Drugs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Compounding Pharmacies Market, By Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Pediatric
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Adults
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Geriatric
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Veterinary
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Compounding Pharmacies Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Avella Specialty Pharmacy
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Central Admixture Pharmacy Services
• Fagron
• Fresenius Kabi AG
• PharMEDium Services
• Institutional Pharmacy Solutions
• Cantrell Drug Company
• Triangle Compounding Pharmacies
• Lorraine's Pharmacy
• Rx3 Compounding Pharmacy
• B Braun Melsungen AG
• Clinigen Group PLC
• QuVa Pharma
• ITC Compounding Pharmacy
• Advanced Pharmacy

10. Section

• Research Methodology
• About Us